Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856

Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856

Schizophrenia is a complex psychopathology whose treatment is still challenging. Given the limitations of existing antipsychotics, there is urgent need for novel drugs with fewer side effects. SEP-363856 (SEP-856) is a novel psychotropic agent currently under phase III clinical investigation for sch...

Full description

Bibliographic Details
Main Authors: Veronica Begni, Alice Sanson, Alessia Luoni, Federica Sensini, Ben Grayson, Syeda Munni, Joanna C. Neill, Marco A. Riva
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
schizophrenia
antipsychotic drug
SEP-363856
trace amine-associated receptor
phencyclidine
amphetamine
Online Access:https://www.mdpi.com/1422-0067/22/8/4119

Internet

https://www.mdpi.com/1422-0067/22/8/4119

Similar Items